Tenofovir News and Research

RSS
HIV drug resistance risk in mothers reduced by tenofovir/emtricitabine with nevirapine during labor

HIV drug resistance risk in mothers reduced by tenofovir/emtricitabine with nevirapine during labor

U.S. trial of new microbicide for HIV prevention to be tested in young women

U.S. trial of new microbicide for HIV prevention to be tested in young women

Pre-exposure prophylaxis for HIV infection

Pre-exposure prophylaxis for HIV infection

Clinton to the rescue again!

Clinton to the rescue again!

Bristol-Myers Squibb receives FDA approval for new formulation of antiretroviral Reyataz

Bristol-Myers Squibb receives FDA approval for new formulation of antiretroviral Reyataz

China taking steps to control the spread of HIV

China taking steps to control the spread of HIV

FDA approves Atripla for the treatment of HIV-1 infection in adults

FDA approves Atripla for the treatment of HIV-1 infection in adults

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

SLU Liver Center to study effectiveness of tenofovir in treating hepatitis B

SLU Liver Center to study effectiveness of tenofovir in treating hepatitis B

Outcome of patients with hepatitis B and HIV infections referred for liver transplantation

Outcome of patients with hepatitis B and HIV infections referred for liver transplantation

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Media reports of drug trials can lack accuracy and reliability

Media reports of drug trials can lack accuracy and reliability

Activist groups hinder important clinical trials of HIV medication

Activist groups hinder important clinical trials of HIV medication

Approval of fixed-dose combination treatments for HIV-1 infection

Approval of fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Roche announces new dosing strategy

Roche announces new dosing strategy